Insulin, which plays a key role in managing blood sugar, also has potential against colitis — a chronic bowel inflammation, finds a study.
The study, conducted on mice, showed that chronic bowel inflammation can be treated effectively by injecting insulin into the rectum.
Insulin works because it activates a gene inside the bowel cells, which has an antioxidant effect and thus may be able to protect the bowel cells from inflammation.
“Existing treatments attack the bowel’s immune system, dampening it, instead our method strengthens the bowel cells’ own defence. It appears to work equally well, and it can probably be used in combination with existing treatments,” said Jorgen Olsen, Professor at the University of Copenhagen in Denmark.
For the study, published in the scientific Journal of Crohn’s and Colitis, the team examined the effect of the treatment in a series of tests on mice with chronic colitis of the type Colitis Ulcerosa.
The cause of these bowel disorders is unknown but they cause patients great discomfort and can involve bloody diarrhoea, anaemia, stomach ache and weight loss.
The researchers have studied the effect of the insulin treatment in various ways.
The team found that treatment with insulin led to a 50 per cent drop in the amount of inflammation, compared to the saltwater control treatment.
Microbes may be helping stir up anxiety and depression in obese people, if results from a new mouse study hold true in humans.
The authors link the effects to how the brain responds to insulin, the hormone that regulates sugar levels in the blood.
The research raises questions about whether changing gut microbes, or changing diet, could help treat these conditions.
Mood, microbes and metabolism
Obesity triggers changes in metabolism — for example, making liver, muscle, fat and other tissues less responsive to insulin. Left untreated, these changes can lead to diabetes.
Obese people also have higher rates of anxiety and depression.
“One could say, ‘Maybe that’s just because they’re obese,’ ” said Harvard Medical School diabetes researcher Ronald Kahn, “but others could say, ‘Maybe there’s a metabolic link.’ ”
“And we asked the question, ‘Maybe the metabolic link is at least partly fueled by the microbiome,’ ” the community of microbes living in a person’s gut, he added.
Those microbes change with diet, and Kahn said different microbes might respond differently to the foods we eat.
To test the theory, Kahn and colleagues fed mice a high-fat diet and studied their behavior as the animals became obese.
They used common tests to gauge anxious and depressed behavior in rodents — for example, how much time the animals spent hiding in a dark box versus exploring a brightly lit area. The more anxious the mouse, the less time it will spend in the light.
Obese mice spent about 25 percent less time in the light than animals on a normal diet, and they scored higher on the other anxiety and depression tests, too.
Return to normal
But those differences disappeared when obese mice were given antibiotics, even though their weight didn’t change much.
“That really says there’s probably something about the microbiome,” Kahn said.
The researchers then tested how the animals’ microbiomes affected mice raised in a sterile environment with no microbes of their own.
Bacteria from obese rodents made these germ-free mice more anxious than microbes from normal mice.
But when germ-free mice got microbes from obese animals that had been given antibiotics, they behaved like normal mice.
To see what parts of the brain might be responsible for the effects, the researchers focused on two regions involved in metabolism and responses to rewards. They found these regions were less responsive to insulin in the obese mice compared with normal-weight animals.
Again, antibiotics returned those responses to normal.
“It was actually quite a surprise,” Kahn said. “Even though we had seen some effects on metabolism in the rest of the body, I was very surprised how dramatic and how clear the effects were also on the brain and on behavior.”
Into the unknown
That doesn’t mean antibiotics are the cure for depression, Kahn warned. The drugs kill good and bad microbes indiscriminately, and taking the medication unnecessarily can contribute to the rising threat of antibiotic resistance.
Also, what happens in mice does not necessarily happen in humans, he added, or it may happen for only some people. So far, there is not much evidence that probiotics help anxious people.
“The difficulty is, both of these things — depression and obesity — are complicated things that have multiple, multiple factors influencing them,” said mental health researcher Gregory Simon at Kaiser Permanente Washington Health Research Institute, who was not part of the study.
Microbes are likely just one factor, along with environment, genetics, social influences and more, Simon added.
But Kahn said his group’s research raised interesting questions about how food affects our behavior.
“I think now we can get some idea that there are a lot of things that are being metabolized by gut bacteria that could affect brain function,” he said.
And he said there might be ways to change brain function by changing those bacteria, by eating helpful microbes or by eating foods that sustain them.